Evolution of Nanorobots In Cancer Treatment Is Likely To Create Growth Opportunities And Expected To Accelerate The Growth Of Medical Robots Market from 2018 to 2025.

The global medical robots market is expected to reach US$ 28,776.6 Mn in 2025 from US$ 5,740.8 Mn in 2017. The market is estimated to grow with a CAGR of 22.3% from 2017-2025. The report highlights the trends prevalent in the global medical robots market and the factors driving the market along with those that act as restraints to its growth. The global medical robots market is witnessing a sheer rise in the current scenario and is expected to expand in the coming years. Rise in the developments for medical robots in Asia is one of the factor to propel the demand of medical robots in the developing nations. However, high cost of surgical procedures and installation is expected to hinder the market growth.

Get Sample Copy at http://bit.ly/2U7oPLf

The evolution of nanorobots for the treatment of cancer is likely to create opportunities for the growth of the medical robots in the coming future. The names nanorobots, nanoids, nanites or nanomites are used to describe the devices. Nano robotics is the technology for the development of the machines or robots which are close to the microscopic scale of a nanometer (10−9 meters). At present, nanorobots play an important role in the field of bio-medicine, importantly for the treatment of cancer, cerebral aneurysm, removal of kidney stones, elimination of defected parts in the DNA structure, and others. Nanorobots are integrated implanted chemical biosensors that are used for detecting the tumor cells in initial stages of cancer development inside a patient’s body. Nanosensors are also used to find the intensity of E-cadherin signals. In most of the cancer cases, drugs have side effects because they can’t differentiate between cancer cells and healthy ones. The nanorobots only target the tumors and didn’t cause clotting elsewhere in the body. Therefore, this offers the cancer treatments free of side effects. Manufacturers and scientists have been investing in the innovative technological developments.

For instance, Arizona State University scientists, in collaboration with researchers from the National Center for Nanoscience and Technology (NCNST) of the Chinese Academy of Sciences, have programmed nanorobots to shrink tumors by cutting off their blood supply. Therefore, the current stages of medical technologies and therapy tools are used for the successful treatment of cancer. The important aspect to achieve a successful treatment is based on the improvement of efficient drug delivery to decrease the side-effects from the chemotherapy.

The prominent players operating in the market of medical robots include Intuitive Surgical, Inc., Stryker, Hocoma AG, Mazor Robotics Ltd., Hansen Medical, Inc. Auris Surgical robotics, Accuray Incorporated, Omnicell Inc., ARxIUM, EKSO Bionics Holdings, Inc., and Kirby Lester, LLC among others.


About Us – The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact us –

Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com